1. IMMU-23. ELIMINATING MONOCYTE CHEMOATTRACTION INVOKES COMPENSATORY NEUTROPHIL INFLUX AND PRONEURAL TO MESENCHYMAL TRANSITION IN GLIOBLASTOMA. (14th November 2022) Authors: Chen, Zhihong; Soni, Nishant; Pinero, Gonzalo; Giotti, Bruno; Eddins, Devon; Lindblad, Katherine; Ross, James; Tsankova, Nadejda; Gutmann, David; Lira, Sergio; Lujambio, Amaia; Ghosn, Eliver; Tsankov, Alexander; Hambardzumyan, Dolores Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. LGG-01. Children with Supratentorial Midline Pilocytic Astrocytomas Exhibit Multiple Progressions and Acquisition of Neurologic Deficits over Time. (3rd June 2022) Authors: Brossier, Nicole; Strahle, Jennnifer; Cler, Samuel; Wallendorf, Michael; Gutmann, David Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 1 Page Start: i87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. LGG-01. NF1 MUTATION DRIVES NEURONAL ACTIVITY-DEPENDENT OPTIC GLIOMA INITIATION. (1st June 2021) Authors: Pan, Yuan; Hysinger, Jared; Schindler, Nicki; Cobb, Olivia; Guo, Xiaofan; Yalçın, Belgin; Anastasaki, Corina; Mulinyawe, Sara; Ponnuswami, Anitha; Scheaffer, Suzanne; Ma, Yu; Chang, Kun-Che; Xia, Xin; Toonen, Joseph; Lennon, James; Gibson, Erin; Liau, Linda; Goldberg, Jeffrey; Monje, Michelle; Gu... Journal: Neuro-oncology Issue: Volume 23(2021)Supplement 1 Page Start: i31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. LGG-06. COMPREHENSIVE GENOMIC CHARACTERIZATION AND INTEGRATED CLINICAL ANALYSIS OF LOW-GRADE GLIOMAS IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1. (1st June 2021) Authors: Fisher, Michael; Jones, David; Li, Yimei; Guo, Xiaofan; Sonawane, Poonam; Waanders, Angela; Phillips, Joanna; Weiss, William; Resnick, Adam; Gosline, Sara; Banerjee, Jineta; Guinney, Justin; Gnekow, Astrid; Kandels, Daniela; Foreman, Nicholas; Korshunov, Andrey; Ryzhova, Marina; Massimi, Luca; Gu... Journal: Neuro-oncology Issue: Volume 23(2021)Supplement 1 Page Start: i32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. LGG-50. Human induced pluripotent stem cell engineering establishes a humanized mouse platform for pediatric low-grade glioma modeling. (3rd June 2022) Authors: Anastasaki, Corina; Chatterjee, Jit; Cobb, Olivia; Scheaffer, Suzanne; Sanapala, Shilpa; Costa, Amanda; Wilson, Anna; Garbow, Joel; Rodriguez, Fausto; Gutmann, David Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 1 Page Start: i100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. LGG-54. Asthma reduces glioma formation by T cell decorin-mediated inhibition of microglia. (3rd June 2022) Authors: Chatterjee, Jit; Sanapala, Shilpa; Cobb, Olivia; Bewley, Alice; Cordell, Elizabeth; Garbow, Joel; Holtzman, Michael; Gutmann, David Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 1 Page Start: i101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Medullary Suprarenal Chromaffinoma. Issue 4503 (26th April 1947) Authors: Gutmann, David Journal: BMJ Issue: Volume 1:Issue 4503(1947) Page Start: 563 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. MYXŒDEMA WITH PERICARDIAL EFFUSION. Issue 1 (January 1946) Authors: Schnitzer, Robert; Gutmann, David Journal: Heart Issue: Volume 8:Issue 1(1946) Page Start: 25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. NFB-02. Maternal high-fat diet exposure increases the proliferation and glial differentiation of the cells of origin for NF1-optic glioma. (3rd June 2022) Authors: Zhang, Kailong; Gutmann, David; Brossier, Nicole Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 1 Page Start: i128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. NFM-01. NF105: A PHASE II PROSPECTIVE STUDY OF CABOZANTINIB (XL184) FOR PLEXIFORM NEUROFIBROMAS IN SUBJECTS WITH NEUROFIBROMATOSIS TYPE 1: A NEUROFIBROMATOSIS CLINICAL TRIAL CONSORTIUM (NFCTC) STUDY. Issue 2 (22nd June 2018) Authors: Shih, Chie-Schin; Blakely, Jaishri; Clapp, Wade; Wolters, Pam; Dombi, Eva; Cutter, Gary; Ullrich, Nichole; Allen, Jeffrey; Packer, Roger; Goldman, Stewart; Gutmann, David; Plotkin, Scott; Rosser, Tena; Robertson, Kent; Widemann, Brigitte; Korf, Bruce; Fisher, Michael Journal: Neuro-oncology Issue: Volume 20:Issue 2(2018)supplement 2 Page Start: i142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗